AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research
The AACR and Bristol-Myers Squibb established this award in 1996 to recognize outstanding achievements in clinical cancer research. The award honors Dr. Joseph H. Burchenal, Honorary Member and Past President of the AACR, and a major figure in clinical cancer research.
Cancer researchers affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.
The Award may only be presented to an individual investigator.
Institutions and/or organizations are not eligible to receive the Award.
Please direct all inquiries pertaining to this award or any other AACR scientific achievement award or lecture to Michael J. Powell, PhD, Deputy Director of Scientific Programs, at [email protected] or by phone at (215) 440-9373.
Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science.
Self-nominations are prohibited.
Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically to https://myaacr.aacr.org. Paper nominations will not be accepted.
Eligible nominations must include the following:
- A nomination letter written in English (Max: 1,000 words), which comprehensively describes the candidate's outstanding recent accomplishments in clinical cancer research. Letter must specifically outline the candidate’s current research activity and indicate how their research holds promise for continued substantive contributions to the cancer field. All publications that directly support the mentioned research accomplishments must be referenced within the provided letter.
- A brief scientific citation (Max: 50 words) highlighting the major scientific contribution(s) justifying the award candidate’s nomination.
See the Program Guidelines and Nomination Instructions for complete details.
Eligible nominees will be considered by an Award Selection Committee composed of an international cohort of cancer research experts appointed by the AACR President. After Award Committee deliberations, primary and alternate award recipient recommendations will be relayed to the AACR Executive Committee for formal ratification.
Selection of the Award recipient shall be made on the basis of the candidate's scientific accomplishments without regard to race, gender, nationality, geographic location, or religious or political views.